Email Alert Subscription |
If you have already signed up for OPKO Health, Inc Email Alerts, please enter your email address in the field below and submit. A confirmation email will be sent. Please click on the link provided in the confirmation email to view your alert subscription.
Latest News
OPKO Health Receives Important U.S. Patent Allowance Read more
OPKO Health Enters into License Agreement with International Health Technology for Next Generation Prostate Cancer Biomarker Panel Read more
OPKO Health Receives Important U.S. Patent Allowance Read more
OPKO Health Announces the Start of Phase 3 Clinical Trials of Rolapitant for the Prevention of CINV Read more
More News


